Literature DB >> 8406802

Growth in and breakdown of purified rabbit small intestinal mucin by Yersinia enterocolitica.

M Mantle1, C Rombough.   

Abstract

The mucus lining of the gastrointestinal tract serves as a protective barrier over the epithelial surface that must be crossed by invading bacteria seeking entry into the mucosa. The gel-forming component of mucus is mucin, a large polymeric glycoprotein. The present study examined the growth of Yersinia enterocolitica (with and without its virulence plasmid) in purified rabbit small intestinal mucin and the ability of bacteria to degrade mucin. Both virulent and nonvirulent organisms showed enhanced growth in mucin-supplemented media compared with unsupplemented media, but only at 37 degrees C and not at 25 degrees C. The effects of mucin were not specific because medium supplemented with bovine serum albumin also enhanced bacterial growth at 37 degrees C. Purified mucin was broken down into lower-molecular-weight components (assessed by monitoring its elution profile on a Sepharose CL-2B column) by plasmid-bearing Y. enterocolitica but not by plasmid-cured organisms. Culturing virulent Y. enterocolitica at 25 degrees C completely suppressed its capacity to degrade mucin, suggesting that this activity depends on plasmid expression. These results were confirmed in similar studies with purified rabbit colonic mucin. Mucin-degrading activity could be demonstrated in spent culture media from virulent Y. enterocolitica incubated at 37 degrees C but not in bacterial membrane preparations. Changes in the elution profiles of small intestinal and colonic mucins exposed to plasmid-bearing Y. enterocolitica at 37 degrees C were consistent with proteolytic depolymerization. The ability to grow well in mucin may help Y. enterocolitica to colonize the intestine, while the production of a mucin-degrading enzyme(s) by plasmid-bearing organisms may assist pathogenic strains to solubilize and penetrate the mucus gel layer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406802      PMCID: PMC281135          DOI: 10.1128/iai.61.10.4131-4138.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  External labeling of cell surface galactose and galactosamine in glycolipid and glycoprotein of human erythrocytes.

Authors:  C G Gahmberg; S I Hakomori
Journal:  J Biol Chem       Date:  1973-06-25       Impact factor: 5.157

2.  Serum resistance associated with virulence in Yersinia enterocolitica.

Authors:  C H Pai; L DeStephano
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

3.  Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis.

Authors:  D A Portnoy; S L Moseley; S Falkow
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

4.  Mucin degradation in human colon ecosystems. Evidence for the existence and role of bacterial subpopulations producing glycosidases as extracellular enzymes.

Authors:  L C Hoskins; E T Boulding
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

5.  Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a "most probable number" method.

Authors:  R S Miller; L C Hoskins
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

6.  In vitro utilization of mucin by Bacteroides fragilis.

Authors:  A M Roberton; R A Stanley
Journal:  Appl Environ Microbiol       Date:  1982-02       Impact factor: 4.792

7.  Heterogeneity of rat goblet-cell mucin before and after reduction.

Authors:  R E Fahim; G G Forstner; J F Forstner
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

8.  Vibrio cholerae metalloproteinase degrades intestinal mucin and facilitates enterotoxin-induced secretion from rat intestine.

Authors:  R S Crowther; N W Roomi; R E Fahim; J F Forstner
Journal:  Biochim Biophys Acta       Date:  1987-06-22

9.  Experimental Yersinia enterocolitica enteritis in rabbits.

Authors:  C H Pai; V Mors; T A Seemayer
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

10.  Polymeric structure of pig small-intestinal mucus glycoprotein. Dissociation by proteolysis or by reduction of disulphide bridges.

Authors:  M Mantle; D Mantle; A Allen
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

View more
  18 in total

Review 1.  Bacteria and host interactions in the gut epithelial barrier.

Authors:  Hiroshi Ashida; Michinaga Ogawa; Minsoo Kim; Hitomi Mimuro; Chihiro Sasakawa
Journal:  Nat Chem Biol       Date:  2011-12-15       Impact factor: 15.040

2.  Two atypical enteropathogenic Escherichia coli strains induce the production of secreted and membrane-bound mucins to benefit their own growth at the apical surface of human mucin-secreting intestinal HT29-MTX cells.

Authors:  Mônica A M Vieira; Tânia A T Gomes; Antonio J P Ferreira; Terezinha Knöbl; Alain L Servin; Vanessa Liévin-Le Moal
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

Review 3.  Host-microbiota interactions in inflammatory bowel disease.

Authors:  Roberta Caruso; Bernard C Lo; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2020-01-31       Impact factor: 53.106

Review 4.  Questions about the behaviour of bacterial pathogens in vivo.

Authors:  H Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

5.  Trichomonad invasion of the mucous layer requires adhesins, mucinases, and motility.

Authors:  M W Lehker; D Sweeney
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

6.  Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.

Authors:  A R Colina; F Aumont; N Deslauriers; P Belhumeur; L de Repentigny
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

7.  Cloning and DNA sequence analysis of an immunogenic glucose-galactose MglB lipoprotein homologue from Brachyspira pilosicoli, the agent of colonic spirochetosis.

Authors:  P Zhang; X Cheng; G E Duhamel
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen.

Authors:  Kirk S B Bergstrom; Julian A Guttman; Mohammad Rumi; Caixia Ma; Saied Bouzari; Mohammed A Khan; Deanna L Gibson; A Wayne Vogl; Bruce A Vallance
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

9.  Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

Authors:  Kirk S B Bergstrom; Vanessa Kissoon-Singh; Deanna L Gibson; Caixia Ma; Marinieve Montero; Ho Pan Sham; Natasha Ryz; Tina Huang; Anna Velcich; B Brett Finlay; Kris Chadee; Bruce A Vallance
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

10.  Kinetics of adhesion of selected fish-pathogenic Vibrio strains of skin mucus of gilt-head sea bream (Sparus aurata L.).

Authors:  M A Bordas; M C Balebona; I Zorrilla; J J Borrego; M A Moriñigo
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.